Learn

This educational webinar aims to update GPs and other clinicians regarding the emerging understanding of sleep, sleep physiology and sleep architecture that has taken insomnia out of a symptoms-based paradigm and into a recognition as a disorder in its own right.

Greater understanding of normal sleep, effective mechanisms for assessing sleep disorders, contemporary non-pharmacological advice are the basis of good sleep management in general practice.

The development of orexin-based agents for pharmacological management provides an alternative to the currently available GABA-agonist hypnotics currently used in insomnia in Australia.

Sponsor: This activity is sponsored by Eisai.  

Learning Outcomes

1. Explain the five elements of normal sleep
2. Outline an evidence-based approach to assessing and differentiating insomnia and circadian rhythm disorder.
3. List an approach to behavioural interventions for insomnia appropriate for primary care
4. Summarise the role of orexin in sleep physiology and wakefulness
5. Illustrate the pros, cons, risks and benefits of available pharmacological agents available for treating insomnia in Australia, including the pharmacological profile of orexin-antagonists.

Details

Disclaimer: Please note, once you click 'Register now' you will be leaving the AMA’s CPD Home website and entering a third-party education provider’s website. If you choose to register for this learning, you will need to provide some of your personal information directly to the third-party education provider. If you have any queries about how third-party education providers use, disclose or store your personal information you should consult their privacy policy.

Upon completion, your CPD activity record may take up to 48 hours to be reflected on your CPD Home Dashboard.